Quarterly Result12 Aug 2026, 04:19 pm
Bacil Pharma Declares Unaudited Q1 FY27 Results
AI Summary
Bacil Pharma Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved these results in a meeting held on August 12, 2026. The company will submit the results to the exchange and make them available on its website. The results will also be published in newspapers in due course. The limited review of the financial results was carried out by the statutory auditors.
Key Highlights
- Bacil Pharma declared unaudited financial results for Q1 FY27.
- Board of Directors approved the results on August 12, 2026.
- Results will be submitted to the exchange and published in newspapers.
- Statutory auditors conducted a limited review of the results.
Price Impact
More from BACPHAR